How has been the historical performance of Bliss GVS Pharma?
Bliss GVS Pharma has shown steady growth in net sales and profits from March 2022 to March 2025, with net sales increasing to INR 809.73 crore and profit after tax rising to INR 90.26 crore. However, total expenditure and liabilities have also increased, indicating rising costs that need monitoring.
Answer:The historical performance of Bliss GVS Pharma shows a mixed trend in various financial metrics over the years.Breakdown:
Bliss GVS Pharma's net sales have shown a steady increase from INR 747.45 crore in March 2022 to INR 809.73 crore in March 2025, with a notable rise from INR 770.24 crore in March 2024. The total operating income followed a similar pattern, reaching INR 809.73 crore in March 2025. However, total expenditure has also increased, amounting to INR 683.04 crore in March 2025, up from INR 619.62 crore in March 2024. Operating profit (PBDIT) excluding other income peaked at INR 163.18 crore in March 2025, although it was lower than the previous year's INR 179.36 crore. Profit before tax increased to INR 125.64 crore in March 2025 from INR 116.87 crore in March 2024, leading to a profit after tax of INR 90.26 crore, up from INR 81.58 crore. The consolidated net profit also rose to INR 84.30 crore in March 2025 from INR 75.45 crore in March 2024. The company's total assets increased to INR 1,300.84 crore in March 2025, compared to INR 1,211.59 crore in March 2024, while total liabilities also rose to INR 1,300.84 crore. The cash flow from operating activities improved to INR 105.00 crore in March 2025 from INR 102.00 crore in March 2024, reflecting a positive trend in cash generation. Overall, while Bliss GVS Pharma has experienced growth in sales and profits, the rising costs and liabilities warrant attention.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
